Entera Bio Reports Positive PK Data for First-in-Class Oral - GlobeNewswire

Retrieved on: 2025-09-15 14:03:36

Tags for this article:

Peptide hormones

Anti-diabetic drugs

Intestinal hormones

Biomolecules

Glucagon-like peptide-2

Glucagon-like peptide-1

Short bowel syndrome

Entera Bio Ltd.

Click the tags to see associated articles and topics

Entera Bio Reports Positive PK Data for First-in-Class Oral - GlobeNewswire. View article details on hiswai:

Excerpt

... peptide platform. Currently, the only approved GLP-2 therapy is Gattex® (teduglutide), which generates approximately $800 million in annual sales ...

Article found on: www.globenewswire.com

View Original Article